ZFP28-DT: A Potential Drug Target or Biomarker for Various Diseases
ZFP28-DT: A Potential Drug Target or Biomarker for Various Diseases
ZFP28-DT, also known as ZFP28 divergent transcript or transcript variant X3, is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
The ZFP28 gene is located on chromosome 16 and encodes for the zinc finger protein 28 (ZFP28), which is a transcription factor that plays a role in regulating gene expression and cell development. ZFP28 has been shown to be involved in a variety of cellular processes, including cell adhesion, migration, and survival.
Transcript variants of the ZFP28 gene have been identified, and some of these variants have been shown to have altered function. One of these variants, known as ZFP28-DT, has been shown to have altered gene expression and cell behavior.
ZFP28-DT has been shown to promote the expression of genes involved in cell adhesion, migration, and survival. It has also been shown to play a role in the development of cancer. For example, studies have shown that high levels of ZFP28-DT expression are associated with poor prognosis in breast cancer.
In addition to its potential role in cancer, ZFP28-DT has also been shown to be involved in neurodegenerative diseases. For example, studies have shown that ZFP28-DT is involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.
ZFP28-DT has also been shown to be involved in autoimmune disorders. For example, studies have shown that ZFP28-DT is involved in the development of autoimmune disorders, including rheumatoid arthritis and multiple sclerosis.
Despite its potential role in a variety of diseases, ZFP28-DT has not yet been studied extensively, and more research is needed to fully understand its function and potential as a drug target or biomarker.
In conclusion, ZFP28-DT is a gene that has been identified as a potential drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand its function and potential as a drug.
Protein Name: ZFP28 Divergent Transcript
The "ZFP28-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZFP28-DT comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZFP3 | ZFP30 | ZFP36 | ZFP36L1 | ZFP36L2 | ZFP37 | ZFP41 | ZFP42 | ZFP57 | ZFP62 | ZFP64 | ZFP64P1 | ZFP69 | ZFP69B | ZFP82 | ZFP90 | ZFP91 | ZFP91-CNTF | ZFP92 | ZFPL1 | ZFPM1 | ZFPM2 | ZFPM2-AS1 | ZFR | ZFR2 | ZFTA | ZFTRAF1 | ZFX | ZFX-AS1 | ZFY | ZFYVE1 | ZFYVE16 | ZFYVE19 | ZFYVE21 | ZFYVE26 | ZFYVE27 | ZFYVE28 | ZFYVE9 | ZFYVE9P1 | ZG16 | ZG16B | ZGLP1 | ZGPAT | ZGRF1 | ZHX1 | ZHX1-C8orf76 | ZHX2 | ZHX3 | ZIC1 | ZIC2 | ZIC3 | ZIC4 | ZIC5 | ZIK1 | ZIM2 | ZIM3 | Zinc finger protein GLI | ZKSCAN1 | ZKSCAN2 | ZKSCAN3 | ZKSCAN4 | ZKSCAN5 | ZKSCAN7 | ZKSCAN8 | ZKSCAN8P1 | ZMAT1 | ZMAT2 | ZMAT3 | ZMAT4 | ZMAT5 | ZMIZ1 | ZMIZ1-AS1 | ZMIZ2 | ZMPSTE24 | ZMYM1 | ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132
